Bafna Pharmaceuticals Ltd. - BAFNAPH, 532989 corporate action history

Bafna Pharmaceuticals Ltd. NSE: BAFNAPH | BSE: 532989

Mid-range Performer

Download real time

88.06 -1.91 (-2.12%)

27.62% Gain from 52W Low

2,753

NSE+BSE Volume

NSE 30 Jul, 2025 3:31 PM (IST)

Bafna Pharmaceuticals Ltd. Bonus history

Bafna Pharmaceuticals Ltd. has not announced any bonus since Jan 1, 2000.

See all forthcoming Bonus and Splits

Bafna Pharmaceuticals Ltd. Split history

Bafna Pharmaceuticals Ltd. has not split the face value of the share since Jan 1, 2000.

See all forthcoming Bonus and Splits

Dividend history for Bafna Pharmaceuticals Ltd.

Bafna Pharmaceuticals Ltd. has declared 1 dividend since Sept. 19, 2013.

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
19 Sep 2013	0.60	FINAL	-	Equity Share

See all forthcoming dividends Check out stocks with top dividend.

Board Meetings - Bafna Pharmaceuticals Ltd.

The latest board meeting for Bafna Pharmaceuticals Ltd. took place on 26 May 2025, for the purpose of Audited Results

Ex-Date	Purpose	Notes
26 May 2025	Audited Results	-
06 Feb 2025	Quarterly Results	-
11 Nov 2024	Quarterly Results	-
13 Aug 2024	Quarterly Results	-
29 May 2024	Audited Results	-
12 Feb 2024	Quarterly Results	-
09 Nov 2023	Quarterly Results	-
11 Aug 2023	Quarterly Results	-
27 May 2023	Audited Results	(Revised)
07 Apr 2023	Others	-

See all Board Meetings for Bafna Pharmaceuticals Ltd.

Bafna Pharmaceuticals Ltd. Rights history

Bafna Pharmaceuticals Ltd. has not issued any rights since Jan 1, 2000.

See all Rights History for Bafna Pharmaceuticals Ltd.

Is Bafna Pharmaceuticals Ltd. worth buying?

23 Votes:

Buy 69.57%

Sell 21.74%

Hold 8.7%